Biotech ETFs in Spotlight, Why They'll Remain

By: ETFdb
Biotechnology ETFs, including the ALPS Medical Breakthroughs ETF ( SBIO ), are on torrid paces in the second quarter. Yes, some of that bullishness is attributable to the industry’s efforts to vanquish the coronavirus, but there’s more to the story.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.